Your browser doesn't support javascript.
loading
Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).
Chakraborty, Pranesh K; Schmitz-Abe, Klaus; Kennedy, Erin K; Mamady, Hapsatou; Naas, Turaya; Durie, Danielle; Campagna, Dean R; Lau, Ashley; Sendamarai, Anoop K; Wiseman, Daniel H; May, Alison; Jolles, Stephen; Connor, Philip; Powell, Colin; Heeney, Matthew M; Giardina, Patricia-Jane; Klaassen, Robert J; Kannengiesser, Caroline; Thuret, Isabelle; Thompson, Alexis A; Marques, Laura; Hughes, Stephen; Bonney, Denise K; Bottomley, Sylvia S; Wynn, Robert F; Laxer, Ronald M; Minniti, Caterina P; Moppett, John; Bordon, Victoria; Geraghty, Michael; Joyce, Paul B M; Markianos, Kyriacos; Rudner, Adam D; Holcik, Martin; Fleming, Mark D.
Afiliação
  • Chakraborty PK; Newborn Screening Ontario, Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada;
  • Schmitz-Abe K; Division of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, MA;
  • Kennedy EK; Ottawa Institute of Systems Biology and BMI, University of Ottawa, Ottawa, ON, Canada;
  • Mamady H; Newborn Screening Ontario, Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada;
  • Naas T; Newborn Screening Ontario, Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada;
  • Durie D; Newborn Screening Ontario, Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada;
  • Campagna DR; Department of Pathology, Boston Children's Hospital, Boston, MA;
  • Lau A; Department of Pathology, Boston Children's Hospital, Boston, MA;
  • Sendamarai AK; Department of Pathology, Boston Children's Hospital, Boston, MA;
  • Wiseman DH; Department of Haematology, Royal Manchester Children's Hospital, Manchester, United Kingdom;
  • May A; Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom;
  • Jolles S; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom;
  • Connor P; Department of Paediatrics, Children's Hospital for Wales, Cardiff, United Kingdom;
  • Powell C; Department of Child Health, Institute of Molecular and Experimental Medicine, School of Medicine, Cardiff University, Children's Hospital for Wales, Cardiff, United Kingdom;
  • Heeney MM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA;
  • Giardina PJ; Division of Hematology-Oncology, Children's Cancer and Blood Foundation Laboratories, Weill Cornell Medical College, New York, NY;
  • Klaassen RJ; Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada;
  • Kannengiesser C; INSERM UMR773, Université Paris Diderot, Assistance Publique des Hospitaux de Paris, Département de Génétique, Hôpital Xavier Bichat, Paris, France;
  • Thuret I; Department of Pediatric Hematology, Hôpital de la Timone, Marseille, France;
  • Thompson AA; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital, Chicago, IL;
  • Marques L; Paediatric Department, Infectious Diseases and Immunodeficiencies Unit, Centro Hospitalar do Porto, Porto, Portugal;
  • Hughes S; Department of Immunology, Royal Manchester Children's Hospital, Manchester, United Kingdom;
  • Bonney DK; Department of Haematology, Royal Manchester Children's Hospital, Manchester, United Kingdom;
  • Bottomley SS; Department of Medicine, Hematology-Oncology Section, University of Oklahoma College of Medicine, Oklahoma City, OK;
  • Wynn RF; Department of Haematology, Royal Manchester Children's Hospital, Manchester, United Kingdom;
  • Laxer RM; Department of Paediatrics and Medicine, The Hospital for Sick Children, University of Toronto, ON, Canada;
  • Minniti CP; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;
  • Moppett J; Bristol Children's Hospital, Bristol, United Kingdom;
  • Bordon V; Department of Pediatric Hemato-Oncology and Stem Cells Transplant, Universitair Ziekenhuis Ghent, Belgium;
  • Geraghty M; Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada;
  • Joyce PB; Department of Chemistry and Biochemistry and Center for Structural and Functional Genomics, Concordia University, Montreal, QC, Canada; and.
  • Markianos K; Division of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, MA;
  • Rudner AD; Ottawa Institute of Systems Biology and BMI, University of Ottawa, Ottawa, ON, Canada;
  • Holcik M; Molecular Biomedicine Program, Children's Hospital of Eastern Ontario Research Institute, Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada.
  • Fleming MD; Department of Pathology, Boston Children's Hospital, Boston, MA;
Blood ; 124(18): 2867-71, 2014 Oct 30.
Article em En | MEDLINE | ID: mdl-25193871
ABSTRACT
Mutations in genes encoding proteins that are involved in mitochondrial heme synthesis, iron-sulfur cluster biogenesis, and mitochondrial protein synthesis have previously been implicated in the pathogenesis of the congenital sideroblastic anemias (CSAs). We recently described a syndromic form of CSA associated with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). Here we demonstrate that SIFD is caused by biallelic mutations in TRNT1, the gene encoding the CCA-adding enzyme essential for maturation of both nuclear and mitochondrial transfer RNAs. Using budding yeast lacking the TRNT1 homolog, CCA1, we confirm that the patient-associated TRNT1 mutations result in partial loss of function of TRNT1 and lead to metabolic defects in both the mitochondria and cytosol, which can account for the phenotypic pleiotropy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Nucleotidiltransferases / Deficiências do Desenvolvimento / Doenças Genéticas Ligadas ao Cromossomo X / Febre / Síndromes de Imunodeficiência / Anemia Sideroblástica / Mutação Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Nucleotidiltransferases / Deficiências do Desenvolvimento / Doenças Genéticas Ligadas ao Cromossomo X / Febre / Síndromes de Imunodeficiência / Anemia Sideroblástica / Mutação Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article